Posterior hypoperfusion in parkinson's disease With and without dementia measured with arterial spin labeling MRI

To determine whether quantitative arterial spin labeling (ASL) can be used to evaluate regional cerebral blood flow in Parkinson's disease with dementia (PDD) and without dementia (PD).

[1]  H Matsuda,et al.  SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  K. Yamashita,et al.  Asymmetrical cerebral perfusion demonstrated by noninvasive arterial spin-labeling perfusion imaging in a patient with corticobasal degeneration , 2010, Japanese Journal of Radiology.

[3]  Takashi Kato,et al.  Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing , 2003, Journal of neurology, neurosurgery, and psychiatry.

[4]  Masanori Kato,et al.  Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies , 2006, Journal of the Neurological Sciences.

[5]  R. Kraft,et al.  Arterial Spin-Labeling in Routine Clinical Practice, Part 1: Technique and Artifacts , 2008, American Journal of Neuroradiology.

[6]  Esben Thade Petersen,et al.  Model‐free arterial spin labeling quantification approach for perfusion MRI , 2006, Magnetic resonance in medicine.

[7]  K. Ishii,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease , 1998, Neurology.

[8]  Albert Gjedde,et al.  Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages , 2010, Brain Structure and Function.

[9]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[10]  N. Schuff,et al.  Gray matter perfusion correlates with disease severity in ALS , 2010, Neurology.

[11]  I. Aiba,et al.  [The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa--measurement by Xe-enhanced CT]. , 1994, Rinsho shinkeigaku = Clinical neurology.

[12]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[13]  L. Henriksen,et al.  Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa , 1985, Acta neurologica Scandinavica.

[14]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[15]  N. Schuff,et al.  Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.

[16]  Kazuto Yoshida,et al.  Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease , 2005, Clinical Neurology and Neurosurgery.

[17]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[18]  A. Parent,et al.  Carpenter's Human Neuroanatomy , 1996 .

[19]  Xavier Golay,et al.  Pulsed star labeling of arterial regions (PULSAR): A robust regional perfusion technique for high field imaging , 2005, Magnetic resonance in medicine.

[20]  C. Ellis,et al.  Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study , 1994, Vision Research.

[21]  M. Goedert,et al.  The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .

[22]  Kim Mouridsen,et al.  The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test–retest study , 2010, NeuroImage.

[23]  M C Bourdel,et al.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[24]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[25]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[26]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[27]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[28]  M. Goedert,et al.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.

[29]  Murat Emre,et al.  Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis , 2008, Annals of neurology.

[30]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.